Research efforts at the Kahlert Institute for Addiction Medicine focus on the development and testing of novel interventions. These can include behavioral therapies, drugs, and innovative technologies to reduce cravings, drug use, and other complications of addiction.
Preclinical research studies employ a variety of techniques, including behavioral, neurophysiological, genetic, molecular, and computational approaches in investigating drugs as diverse as opioids, cocaine, amphetamines, cannabis, nicotine, and alcohol.